Report for: Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial

Title	Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial
Published in	Trials, January 2019
DOI	10.1186/s13063-018-3134-1
Pubmed ID	30621764
Authors	James Dear

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United Kingdom	2	67%
Unknown	1	33%

Type	Count	As %
Scientists	2	67%
Practitioners (doctors, other healthcare professionals)	1	33%

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	31	100%

Readers by professional status	Count	As %
Student > Bachelor	4	13%
Student > Doctoral Student	3	10%
Student > Ph. D. Student	3	10%
Other	2	6%
Professor	2	6%
Other	4	13%
Unknown	13	42%

Readers by discipline	Count	As %
Medicine and Dentistry	8	26%
Pharmacology, Toxicology and Pharmaceutical Science	5	16%
Nursing and Health Professions	2	6%
Psychology	2	6%
Unspecified	1	3%
Other	1	3%
Unknown	12	39%

Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose…